FRI advances the patient care journey in Pulmonary Hypertension.
“Innovative technologies are necessary to improve diagnosis and treatments in patients with pulmonary hypertension (PH). As a non-invasive tool that gives detailed information about the smallest blood vessels of the lungs, Functional Respiratory Imaging (FRI) could become a pivotal tool to evaluate novel disease-modifying therapies in clinical trials and to improve early diagnosis of this disease. Dr. Roham Zamanian, Associate Professor of Medicine at Stanford University School of Medicine and the director of the Adult Pulmonary Hypertension Service at the Vera Moulton Wall Center for Pulmonary Vascular Disease, explains how his current collaborations with the Fluidda team have convinced him that FRI could revolutionize the way that PH is diagnosed and treated.”Dr. Roham Zomanian – Associate Professor of Medicine
(Pulmonary and Critical Care Medicine) at Stanford
Hospital and Clinics.
This is the first paragraph of a recent interview with Dr Zamanian in Fluidda Magazine #3.
To read the full article, click here.
All Fluidda Magazines can be downloaded via the website.
FRI, Hypertension, Magazine, PH, Pulmonary